{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:49:57Z","timestamp":1790005797978,"version":"4.0.1"},"reference-count":60,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2015.00269","type":"journal-article","created":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T13:22:37Z","timestamp":1444051357000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO\/GC signaling"],"prefix":"10.3389","volume":"6","author":[{"given":"Marcondes A. B.","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Bruder-Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefany B. A.","family":"Cau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rheure A. M.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola L. A. C.","family":"Mestriner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael S.","family":"Fais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhian M.","family":"Touyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita C.","family":"Tostes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.lfs.2005.12.041","article-title":"Role of nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) in the regulation of blood pressure by leptin in lean and obese rats","volume":"79","author":"Beltowski","year":"2006","journal-title":"Life Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"9747","DOI":"10.1073\/pnas.97.17.9747","article-title":"An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice","volume":"97","author":"Brandes","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","article-title":"Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction","volume":"59","author":"Briones","year":"2012","journal-title":"Hypertension"},{"key":"B4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1042\/CS20140456","article-title":"Vascular injury in diabetic db\/db mice is ameliorated by atorvastatin: role of Rac1\/2-sensitive Nox-dependent pathways","volume":"128","author":"Bruder-Nascimento","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1758-5996-6-90","article-title":"The involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes","volume":"6","author":"Bruder-Nascimento","year":"2014","journal-title":"Diabetol. Metab. Syndr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1161\/CIRCULATIONAHA.106.668715","article-title":"Aldosterone and cardiovascular disease: smoke and fire","volume":"114","author":"Calhoun","year":"2006","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/01.HYP.0000154365.30593.d3","article-title":"Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src","volume":"45","author":"Callera","year":"2005","journal-title":"Hypertension"},{"key":"B9","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/cvr\/cvr131","article-title":"Vascular proinflammatory responses by aldosterone are mediated via c-Src trafficking to cholesterol-rich microdomains: role of PDGFR","volume":"91","author":"Callera","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1475-2840-13-88","article-title":"Inhibition of calpain reduces oxidative stress and attenuates endothelial dysfunction in diabetes","volume":"13","author":"Chen","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants","volume":"378","author":"Danaei","year":"2011","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/sj.bjp.0703144","article-title":"Potassium- and acetylcholine-induced vasorelaxation in mice lacking endothelial nitric oxide synthase","volume":"129","author":"Ding","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1751-7176.2011.00511.x","article-title":"Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics","volume":"13","author":"Epstein","year":"2011","journal-title":"J. Clin. Hypertens. (Greenwich)."},{"key":"B14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.bbadis.2010.03.006","article-title":"Menage a trois: aldosterone, sodium and nitric oxide in vascular endothelium","volume":"1802","author":"Fels","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1161\/01.HYP.23.6.1121","article-title":"Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions","volume":"23","author":"F\u00f6rstermann","year":"1994","journal-title":"Hypertension"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace","volume":"113","author":"F\u00f6rstermann","year":"2006","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2337\/db14-0670","article-title":"Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes","volume":"64","author":"Garg","year":"2015","journal-title":"Diabetes"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1172\/JCI29807","article-title":"Deconstructing endothelial dysfunction: soluble guanylyl cyclase oxidation and the NO resistance syndrome","volume":"116","author":"Gladwin","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S2213-8587(14)70102-0","article-title":"Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment","volume":"2","author":"Global Burden of Metabolic Risk Factors for Chronic Diseases","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1088\/0967-3334\/17\/4\/004","article-title":"Half-life of nitric oxide in aqueous solutions with and without haemoglobin","volume":"17","author":"Hakim","year":"1996","journal-title":"Physiol. Meas."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s001250051551","article-title":"Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus","volume":"43","author":"Heitzer","year":"2000","journal-title":"Diabetologia"},{"key":"B23","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.1161\/01.RES.88.2.e14","article-title":"Mechanisms underlying endothelial dysfunction in diabetes mellitus","volume":"88","author":"Hink","year":"2001","journal-title":"Circ. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1111\/j.1523-1755.2004.00524.x","article-title":"Plasma aldosterone concentration in the patient with diabetes mellitus","volume":"65","author":"Hollenberg","year":"2004","journal-title":"Kidney Int."},{"key":"B25","doi-asserted-by":"crossref","first-page":"H762","DOI":"10.1152\/ajpheart.2000.278.3.H762","article-title":"In eNOS knockout mice skeletal muscle arteriolar dilation to acetylcholine is mediated by EDHF","volume":"278","author":"Huang","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/sj.bjp.0706194","article-title":"Two distinct pathways account for EDHF-dependent dilatation in the gracilis artery of dyslipidaemic hApoB+\/+mice","volume":"145","author":"Krummen","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejphar.2014.01.043","article-title":"Eplerenone mimics features of the alternative activation in macrophages obtained from patients with heart failure and healthy volunteers","volume":"726","author":"Labuzek","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1111\/bph.12350","article-title":"Boldine improves endothelial function in diabetic db\/db mice through inhibition of angiotensin II-mediated BMP4-oxidative stress cascade","volume":"170","author":"Lau","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"E975","DOI":"10.1152\/ajpendo.00699.2013","article-title":"Anthocyanin increases adiponectin secretion and protects against diabetes-related endothelial dysfunction","volume":"306","author":"Liu","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1006\/bbrc.1993.1735","article-title":"Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors","volume":"193","author":"Malinski","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/nyas.12395","article-title":"New insights into insulin action and resistance in the vasculature","volume":"1311","author":"Manrique","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"F78","DOI":"10.1152\/ajprenal.00077.2007","article-title":"Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone","volume":"293","author":"Mej\u00eda-Vilet","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1210\/en.2004-1130","article-title":"Eplerenone blocks nongenomic effects of aldosterone on the Na+\/H+ exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels","volume":"146","author":"Michea","year":"2005","journal-title":"Endocrinology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/01.HYP.0000226054.53527.bb","article-title":"Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity","volume":"48","author":"Nagata","year":"2006","journal-title":"Hypertension"},{"key":"B35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/MNH.0b013e32834fb25b","article-title":"Extrarenal effects of aldosterone","volume":"21","author":"Nguyen Dinh Cat","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/HYPERTENSIONAHA.107.088955","article-title":"Influence of acute and chronic mineralocorticoid excess on endothelial function in healthy men","volume":"50","author":"Nietlispach","year":"2007","journal-title":"Hypertension"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1073\/pnas.0813069106","article-title":"Potassium softens vascular endothelium and increases nitric oxide release","volume":"106","author":"Oberleithner","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/ndt\/gfl780","article-title":"Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney","volume":"22","author":"Onozato","year":"2007","journal-title":"Nephrol. Dial. Transplant"},{"key":"B39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ejphar.2006.08.086","article-title":"Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db\/db mice","volume":"551","author":"Pannirselvam","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2012.09.034","article-title":"Aldosterone and angiotensin: role in diabetes and cardiovascular diseases","volume":"697","author":"Patel","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005344-199701000-00002","article-title":"Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin","volume":"29","author":"Pieper","year":"1997","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1475-2840-10-94","article-title":"Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report","volume":"10","author":"Resch","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0021-9150(02)00363-5","article-title":"Aldosterone induces contraction of the resistance arteries in man","volume":"166","author":"Romagni","year":"2003","journal-title":"Atherosclerosis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/157016112799304969","article-title":"Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists","volume":"10","author":"Ronconi","year":"2012","journal-title":"Curr. Vasc. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/01.HYP.0000083298.23119.16","article-title":"Rapid nongenomic effects of aldosterone on human forearm vasculature","volume":"42","author":"Schmidt","year":"2003","journal-title":"Hypertension"},{"key":"B46","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1161\/01.CIR.0000155238.70797.4E","article-title":"Investigation of vascular responses in endothelial nitric oxide synthase\/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo","volume":"111","author":"Scotland","year":"2005","journal-title":"Circulation"},{"key":"B47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1161\/ATVBAHA.111.240697","article-title":"Aldosterone induces vascular insulin resistance by increasing insulin-like growth factor-1 receptor and hybrid receptor","volume":"32","author":"Sherajee","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1042\/CS20140758","article-title":"Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus","volume":"129","author":"Silva","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1172\/JCI28371","article-title":"Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels","volume":"116","author":"Stasch","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1476-5381.2012.02194.x","article-title":"Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications","volume":"168","author":"Toda","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1590\/S0100-879X2004000800018","article-title":"Reactive oxygen species and angiotensin II signaling in vascular cells \u2013 implications in cardiovascular disease","volume":"37","author":"Touyz","year":"2004","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/cvr\/cvt125","article-title":"Defective Nrf2-dependent redox signalling contributes to microvascular dysfunction in type 2 diabetes","volume":"100","author":"Velmurugan","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"B55","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/sj.bjp.0702858","article-title":"Acetylcholine-induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase","volume":"128","author":"Waldron","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.atherosclerosis.2007.10.003","article-title":"Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus","volume":"198","author":"Wenzel","year":"2008","journal-title":"Atherosclerosis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1159\/000088101","article-title":"Intact endothelium-dependent dilation and conducted responses in resistance vessels of hypercholesterolemic mice in vivo","volume":"42","author":"W\u00f6lfle","year":"2005","journal-title":"J. Vasc. Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/eurheartj\/16.suppl_N.98","article-title":"Aldosterone and heart failure","volume":"16","author":"Zannad","year":"1995","journal-title":"Eur. Heart J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mce.2014.08.003","article-title":"Aldosterone induces C-reactive protein expression via MR-ROS-MAPK-NF-kappaB signal pathway in rat vascular smooth muscle cells","volume":"395","author":"Zhang","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"}],"container-title":["Frontiers in Physiology"],"original-title":[],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T03:16:15Z","timestamp":1567221375000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fphys.2015.00269\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,5]]},"references-count":60,"URL":"https:\/\/doi.org\/10.3389\/fphys.2015.00269","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,5]]}}}